Operating profit EBITDA: empro.my (EMPG)

Brandmark of Empro Group (EMPG)

The resilience of Empro Group Inc (EMPG) is based on patents and Asian distribution. Total EBITDA for the period reflects business dynamics, with the indicator settling at . The defensive nature of the sector ensures a steady cash flow, although the risk of clinical trial failure and fierce competition in dermatology create certain pressure on the asset's quotes.

Profit before payment of interest, taxes and amortization: empro.my (EMPG) for 07/04/2022 - 11/10/2026

Summary analytical data breakdowns for Empro Group (EMPG)

- stock value and consensus price forecast:
Market Chart Empro Corporation|EMPG - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization Empro Group|EMPG - Enterprise Value
- book value of equity indicators:
Net Assets per Share Empro Group|EMPG - Company Book Value|Capitalization to Book Value Ratio empro.my|EMPG - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Empro Group Inc|EMPG - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Empro Group Inc.|EMPG - Company Debts|Debts to Book Capitalization Ratio Empro Group|EMPG - Company Long-Term Debt|Company Short-Term Loans and Borrowings Empro Group|Immediate Liquidity empro.my
- company profitability and valuation multiples indicators:
EMPG - Net Income|Expected Net Income Empro Group Inc|EMPG - P/E Multiple|Forward Price to Earnings Multiple empro.my|EMPG - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Empro Group|EMPG - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Empro Group|EMPG - Net earnings per share for the last 12 months|Quarterly EPS earnings growth empro.my|EMPG - Earnings per share growth in current year|Net earnings per share change forecast for next year Empro Group Inc
Analysis of all company metrics:Empro Corporation, EMPG
Manufactured product of Empro

This indicator captures net cash flow from operating activities before asset depreciation, excluding accounting adjustments to assess real solvency. By analyzing the operating profit of Empro Group Inc (EMPG), an investor can gauge the monetization efficiency of micropigmentation services and cosmeceutical sales in Southeast Asia, allowing for the differentiation of sustainable profit growth from temporary market fluctuations.

Competitors of Empro Group Inc (EMPG)

Operating income before deduction of amortization Krystal Biotech Corp. (KRYS)|APGE - Profit before payment of interest, taxes and amortization|ARQT - Operating profit EBITDA|VCEL: Operating profit EBITDA|ORKA - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Sanara MedTech, Inc.|Operating profit before amortization DBVT (DBV Technologies SA)|Operating profit EBITDA SLSN|DERM - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Forte Biosciences FBRX|SLGL - Operating profit before deduction of amortization|AXIL - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization MDCX|verrica.com (VRCA) - Profit before payment of interest, taxes and amortization|Hoth Therapeutics - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Biofrontera, Inc.|Profit before interest, taxes and amortization VYNE Therapeutics Inc VYNE|Operating profit before deduction of amortization SNOA (Sonoma Pharmaceuticals)|QNRX (quoinpharma.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA AZTR (Azitra, Inc.)|Operating profit before depreciation charges dermatarx.com|ELAB - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization RVNC (Revance Therapeutics Inc.)